Science, Computers & Technology Civil Procedure Administrative Agency

Patents Patent Trial and Appeal Board Inter Partes Review (IPR) Proceeding Patent Litigation Appeals Pharmaceutical Industry FDA Patent Infringement USPTO Pharmaceutical Patents SCOTUS Claim Construction Biosimilars America Invents Act Patent-Eligible Subject Matter BPCIA Prescription Drugs Obviousness Broadest Reasonable Interpretation Standard Generic Drugs Administrative Procedure Act Popular Sandoz v Amgen Amgen Cuozzo Speed Technologies v Lee CLS Bank v Alice Corp Preliminary Injunctions ANDA Orphan Drugs Prior Art Section 101 Section 340B FTC Abstract Ideas EPA HHS Medical Devices Covered Business Method Patents Hatch-Waxman ITC Jurisdiction Healthcare Affordable Care Act Cuozzo Speed Technologies Judicial Review Sandoz Software Patents FDCA Intellectual Property Litigation Pesticides Reversal Standard of Review Standing Summary Judgment Trademarks Administrative Proceedings Commercial Marketing EU Manufacturers Patent Applications Patent Invalidity Section 337 Software Trademark Trial and Appeal Board ALJ B&B Hardware v Hargis Industries Corporate Counsel Data Protection Data Security FDA Approval Infringement LabMD Motion to Amend Patent Dance Patent Reform Patent-in-Suit Preemption Biologics Dismissals FTC Act HRSA Issue Preclusion Notice Requirements Oral Argument Patent Term Adjustment Personally Identifiable Information PHRMA Remand Vacated Burden of Proof Chevron Deference Computer-Related Inventions Data Breach Enfish v Microsoft Enforcement Actions Ex Partes Reexamination Imports Intellectual Property Protection Labeling Life Sciences Likelihood of Confusion Non-Appealable Decisions Safe Harbors Stem cells Trademark Infringement Administrative Appeals Administrative Authority Antitrust Litigation Apotex Attorney's Fees Biotechnology Cybersecurity Declaratory Judgments Defend Trade Secrets Act (DTSA) Discovery Dispute Resolution Drones Due Process En Banc Review Endangered Species Act (ESA) Enforcement Enhanced Damages Evidence Expert Testimony False Claims Act (FCA) FCC FFDCA Final Judgment First Amendment Halo v Pulse Hospitals Likelihood of Success Mayo v. Prometheus Medtronic Misleading Statements Motion to Dismiss Notice and Comment Off-Label Promotion Off-Label Use Patent Ownership Patent Validity Petition for Writ of Certiorari Post-Grant Review Prevailing Party Registration Requirement Statute of Limitations Trade Secrets Unmanned Aircraft Systems Willful Infringement Writ of Mandamus Wyndham 35 U.S.C. § 284 Abuse of Discretion Amarin CAFC Case Consolidation Certiorari Citizen Petitions Classen Immunotherapies Confidential Information Copyright Infringement Covered Business Method Proceedings Covered Entities DNA Doctrine of Equivalents DOJ Elan Pharmaceuticals Federal Aviation Administration (FAA) Federal Register Federal Rules of Civil Procedure FIFRA Free Speech Google Hana Financial v Hana Bank Health Care Providers Induced Infringement Kirtsaeng v. John Wiley & Sons Microsoft Misappropriation Noninfringement On-Sale Bar Open Internet Rules Otsuka Pharmaceutical Patent Royalties Permanent Injunctions Request for Continued Examination Rulemaking Process Subject Matter Jurisdiction Tacking Tariff Act of 1930 Trademark Registration US Fish and Wildlife Service Young Lawyers 510(k) RTA aBLA Airspace Antitrust Provisions Appellate Review Apple Arbitrary and Capricious Ariosa Article III Assignor Estoppel Bascom Global v AT&T Mobility Bayer Biofuel Broadband Burden-Shifting Canada Chemicals Class Action Clear Error Standard Collateral Estoppel Colleges Communications Act 2003 Copyright Covidien DaimlerAG Damages Data Privacy Declaration DHS Digital Goods Disclosure Disgorgement ECHA Electronics Ethicon Examiners Exhaustion Doctrine Final Rules Garmin International General Motors Graham Factors Hackers Human Genes Injunctions Innovation Act Insecticide Internet Inventors IP License Joint Infringement Judgment As A Matter Of Law Kimble v Marvel Enterprises Lanham Act License Agreements Litigation Strategies Marketing McRo v Bandai Namco Merck Method Claims Motion to Vacate Mylan Pharmaceuticals Myriad Myriad-Mayo National Marine Fisheries Service Nautilus Inc. v. Biosig Instruments OPT Oracle Orange Book Order to Stay PATENT Act Patent Cooperation Treaty Patent Exhaustion Patent Prosecution Personal Jurisdiction Petition For Rehearing Pharmacies Pharmacist Phillips Standard Preponderance of the Evidence Product Labels Product of Nature Doctrine Proposed Amendments Qui Tam Reaffirmation Registration Reissue Patents Res Judicata Reversible Error Rules of Practice SEC Section 5 Section 7 Sequenom Software Developers Split of Authority State and Local Government Statutory Authority STEM Surveillance Tax Tribunal Technology Telecommunications Teva Pharmaceuticals Teva v Sandoz The Copyright Act Trademark Litigation Transfer of Venue TRO UK Unfair Competition Unfair or Deceptive Trade Practices USPTO Pilot Program Venue Visas Whistleblower Protection Policies Whistleblowers Wifi AbbVie Abuse of Process Additive Manufacturing Administrative Hearings Admissible Evidence Advanced Notice of Proposed Rulemaking (ANPRM) Adverse Employment Action AFCP Amazon Amended Complaints Analogous Art Anti-Retaliation Provisions Anticipation AOL Apple v Samsung Assumption of the Risk AstraZeneca Audits Australia Australian Patent Office Automobile Recall Automotive Industry Bifurcation Bilski Biologics Price Competition and Innovation Act of 2009 Biomass Bitcoin Board of Patent Appeals Boehringer Books & Records Breach of Warranty Bylaws C-Suite Executives CA Supreme Court Cadence Pharmaceuticals Inc. Cancellation Rights Carbon Emissions Carve Out Provisions Cause of Action Accrual CCPs CEA Cease and Desist CEOs Certification Marks Certifications CFTC Chevron v NRDC Cipro Cisco Cisco v CommilUSA Civil Service Reform Act CJEU Claim Amendments Claims Limitations Period Clean Water Act Clinical Trials Comment Period Commercial Use Communications Act of 1934 Compelled Speech Complex Litigation Compliance Computer Fraud and Abuse Act (CFAA) Consent Constitutional Challenges Consumer Watchdog Continuing Violation Theory Continuous Applications Conversion Copyright Litigation Counterclaims Credit Cards Crime Statistics Criminal Investigations Critical Habitat Customer-Loyalty Programs Cybor Corp v FAS Technologies Daiichi Sankyo DaimlerChrysler v Bauman Data Collection Data Retention Data-Sharing DDR Holdings v Hotels.com De Novo Standard of Review Declaratory Relief Deed of Trust Defense Strategies Deferred Prosecution Agreements Department of Revenue Depositions Design Patent Determination on Remand Diagnostic Method Dickey-Wicker Amendment Dietary Supplements Digital Data Digital Downloads Direct Infringement Disability Disclosure Requirements Dismissal With Prejudice Disparagement Distribution Rules Divided Infringement Doctrine of Prosecution Disclaimer Dodd-Frank Domain Names Domestic Industry Requirement DQSA Drug Compounding Drug Safety Duty to Warn eBay eBay Test Economic Espionage Act Electronic Communications Employment Contract Energy Enforcement Authority EPO Equal Protection Equitable Estoppel Equitable Tolling Equivalency Determinations Ericsson Estoppel European Commission European Food Safety Authority (EFSA) Ex Parte Exclusive Remedy Exclusivity Expert Witness Express Warranty Extraterritoriality Rules Failure To Warn Fair Use False Statements Farm Bureau FCPA FDCPA Federal Pleading Requirements Federal v State Law Application FIFA Filing Requirements Final Action Financial Conduct Authority (FCA) FOIA Ford Motor Foreign Corporations Foreign Patent Applications Foreign Students Form F-1 Former Employee France FRCP 19 FRCP 52(a)(2) Fresenius FTC v Wyndham Fund Managers Future Harm GAAP GAO Genetic Testing Genzyme Germany Goods or Services Goodyear Government Claims Government Investigations Greenhouse Gas Emissions gTLD Guilty Pleas H-1B Hana Bank Health Claims HELP Hewlett-Packard Highly-Skilled Workers Visa HIPAA Hitachi Honest Belief Defense Hospira HTC IBM ICANN Implied Warranties Importers In-Person Exam Incentives Indirect Infringement Individual Accountability Inducements Inherent Disclosure Doctrine Initial Determination (ID) Injunctive Relief Injury-in-Fact Insider Trading Intangible Property Interference Claims Internal Controls Internet of Things Internet Service Providers (ISPs) Interpretive Rule Interstate Commerce Investigations Investment Adviser Investment Advisers Act of 1940 Investment Company Act of 1940 IP Assignment Agreements IPEC Joint Enterprise Theory JPMorgan Chase Judicial Discretion Judicial Exception Jury Questions Jury Trial Kappos Laches Law Enforcement Lexmark Licensing Rights Licensing Rules Life Technologies v Promega Limelight v Akamai Mandamus Petitions Material Misstatements Medicaid Medicare Mensing Misbranding Mobile Devices Mootness Motion for Reconsideration Motion for Sanctions Motion for Summary Judgment Motion Picture Industry Motion to Exclude Motion To Stay Motion to Withdraw Motions to Stay Proceedings Municipal Broadband Providers Mutual Funds Nanomaterials Nanosilver Natural Resources Defense Council Neither Admit Nor Deny Settlements New Guidance New York Times News Stories NFL NHTSA NIH Noerr-Pennington Doctrine Notice Provisions Novartis NPRM NRDC Nunc Pro Tunc NuVasive Obama Administration OCIE Octane Fitness v. ICON OMB OMHA Omnicare Oracle v Google Out-of-State Companies Patent Amendments Patent Assignment and Transfer Agreement (PATA) Patent Examinations Patent Expiration Patent Portfolios Patent Prosecution Highway Patentability Search Pay-For-Delay Penalties Personal Data Personalized Medicine Petition for Rulemaking Petitions for Review PHSA Physicians Pleading Standards Police Policies and Procedures Precedential Opinion Premarket Approval Applications Prescription Drug Coverage Priority Date Cutoff Priority Patent Claims Privacy Policy Private Right of Action Product Defects Professional Conferences Profits Proportionality Proposed Legislation Proposed Rules Public Comment Public Health Service Act Public Interest Public Notaries Public Records Public Records Act Purple Book Putative Class Actions RAND REACH Real Party in Interest Reasonably Continuous Exercise of Diligence Standard Redskins Renewable Energy Request For Information Required Documentation Research Funding Restraining Orders Retaliation Reverse Payment Settlement Agreements Revocation Risk Alert Roxane Laboratories Rule 10b-5 Rule 54(b) Sales Tax Same-Day Continuations Samsung Sanctions Sarbanes-Oxley Science Advisory Board Scientific Research Scope of the Claim Seal SEC Examination Priorities Section 16 Section 706 Securities Securities Exchange Act Securities Fraud Settlement Conferences Sherley v Sebelius Shot Clock Sound Recording Copyrights South Africa Spoliation Sponsors Sprint Square Standard Essential Patents Standard of Proof Stark Law State Medical Board Statutory Interpretation Strategic Enforcement Plan StreetView STRONG Patents Act Students Subject Matter Experts Subpoenas Substantial Evidence Standard Sunrise Periods Supplemental Examination Suprema Swaps Tariffs Technology Sector Telehealth Terminal Disclaimer Termination The Patent Act The Slants Time Extensions Time-Barred Claims Title II Tolling Toxic Substances Control Act (TSCA) Toyota Trading Platforms Trans-Pacific Partnership Transaction Privilege Tax Trial de Novo Trial Preparation Unified Patent Court Unitary Patent US Army Corps of Engineers Vaccinations Validity Vehicle Navigation Systems Vicarious Liability Virtual Currency Volkswagen WARF Waters of the United States WEC Carolina v Miller White Collar Crimes Willful Blindness Wireless Industry Written Descriptions Yates Memorandum